Cargando…
A Compositive Strategy to Study the Pharmacokinetics of TCMs: Taking Coptidis Rhizoma, and Coptidis Rhizoma-Glycyrrhizae Radix et Rhizoma as Examples
Pharmacokinetic studies are crucial for elucidating the effective constituents and formula compatibility of traditional Chinese medicines (TCMs). However, studies have usually been limited to single dosages and detection of systemic blood concentrations. To obtain comprehensive pharmacokinetic infor...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6222803/ https://www.ncbi.nlm.nih.gov/pubmed/30111723 http://dx.doi.org/10.3390/molecules23082042 |
_version_ | 1783369292321914880 |
---|---|
author | Li, Qiao Yang, Yan Zhou, Ting Wang, Rui Li, Na Zheng, Min Li, Yuan-Yuan Zhang, Ji-Quan Wu, Fei Yang, Bai-Can Ma, Yue-Ming Ma, Bing-Liang |
author_facet | Li, Qiao Yang, Yan Zhou, Ting Wang, Rui Li, Na Zheng, Min Li, Yuan-Yuan Zhang, Ji-Quan Wu, Fei Yang, Bai-Can Ma, Yue-Ming Ma, Bing-Liang |
author_sort | Li, Qiao |
collection | PubMed |
description | Pharmacokinetic studies are crucial for elucidating the effective constituents and formula compatibility of traditional Chinese medicines (TCMs). However, studies have usually been limited to single dosages and detection of systemic blood concentrations. To obtain comprehensive pharmacokinetic information, here we propose a multi-dosage and multi-sampling (blood from portal vein or systemic circulation, and liver) strategy to comparatively study the pharmacokinetics of multi-form TCMs, i.e., pure constituents, TCMs, or TCM formula extracts. Based on this strategy, we studied the pharmacokinetics of pure berberine, berberine in Coptidis Rhizoma (CRE), and berberine in Coptidis Rhizoma-Glycyrrhizae Radix et Rhizoma extracts (CR-GRE). After simple calculation and comparison of the obtained area under the curve (AUC) values, the results revealed the drastically different pharmacokinetic properties of pure berberine compared to CRE and CR-GRE. The results contribute to explaining the pharmacological loss of berberine activity after purification and the compatibility of the CR-GR drug pair. The results also innovatively showed that it was intestinal absorption that differentiated the pharmacokinetics of CRE and pure berberine, and CRE and CR-GRE. In conclusion, we propose a composite strategy to comparatively study the pharmacokinetics of TCMs, which could provide sufficient information to obtain a comprehensive view, before follow-up mechanism-of-action studies. |
format | Online Article Text |
id | pubmed-6222803 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-62228032018-11-13 A Compositive Strategy to Study the Pharmacokinetics of TCMs: Taking Coptidis Rhizoma, and Coptidis Rhizoma-Glycyrrhizae Radix et Rhizoma as Examples Li, Qiao Yang, Yan Zhou, Ting Wang, Rui Li, Na Zheng, Min Li, Yuan-Yuan Zhang, Ji-Quan Wu, Fei Yang, Bai-Can Ma, Yue-Ming Ma, Bing-Liang Molecules Article Pharmacokinetic studies are crucial for elucidating the effective constituents and formula compatibility of traditional Chinese medicines (TCMs). However, studies have usually been limited to single dosages and detection of systemic blood concentrations. To obtain comprehensive pharmacokinetic information, here we propose a multi-dosage and multi-sampling (blood from portal vein or systemic circulation, and liver) strategy to comparatively study the pharmacokinetics of multi-form TCMs, i.e., pure constituents, TCMs, or TCM formula extracts. Based on this strategy, we studied the pharmacokinetics of pure berberine, berberine in Coptidis Rhizoma (CRE), and berberine in Coptidis Rhizoma-Glycyrrhizae Radix et Rhizoma extracts (CR-GRE). After simple calculation and comparison of the obtained area under the curve (AUC) values, the results revealed the drastically different pharmacokinetic properties of pure berberine compared to CRE and CR-GRE. The results contribute to explaining the pharmacological loss of berberine activity after purification and the compatibility of the CR-GR drug pair. The results also innovatively showed that it was intestinal absorption that differentiated the pharmacokinetics of CRE and pure berberine, and CRE and CR-GRE. In conclusion, we propose a composite strategy to comparatively study the pharmacokinetics of TCMs, which could provide sufficient information to obtain a comprehensive view, before follow-up mechanism-of-action studies. MDPI 2018-08-15 /pmc/articles/PMC6222803/ /pubmed/30111723 http://dx.doi.org/10.3390/molecules23082042 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Li, Qiao Yang, Yan Zhou, Ting Wang, Rui Li, Na Zheng, Min Li, Yuan-Yuan Zhang, Ji-Quan Wu, Fei Yang, Bai-Can Ma, Yue-Ming Ma, Bing-Liang A Compositive Strategy to Study the Pharmacokinetics of TCMs: Taking Coptidis Rhizoma, and Coptidis Rhizoma-Glycyrrhizae Radix et Rhizoma as Examples |
title | A Compositive Strategy to Study the Pharmacokinetics of TCMs: Taking Coptidis Rhizoma, and Coptidis Rhizoma-Glycyrrhizae Radix et Rhizoma as Examples |
title_full | A Compositive Strategy to Study the Pharmacokinetics of TCMs: Taking Coptidis Rhizoma, and Coptidis Rhizoma-Glycyrrhizae Radix et Rhizoma as Examples |
title_fullStr | A Compositive Strategy to Study the Pharmacokinetics of TCMs: Taking Coptidis Rhizoma, and Coptidis Rhizoma-Glycyrrhizae Radix et Rhizoma as Examples |
title_full_unstemmed | A Compositive Strategy to Study the Pharmacokinetics of TCMs: Taking Coptidis Rhizoma, and Coptidis Rhizoma-Glycyrrhizae Radix et Rhizoma as Examples |
title_short | A Compositive Strategy to Study the Pharmacokinetics of TCMs: Taking Coptidis Rhizoma, and Coptidis Rhizoma-Glycyrrhizae Radix et Rhizoma as Examples |
title_sort | compositive strategy to study the pharmacokinetics of tcms: taking coptidis rhizoma, and coptidis rhizoma-glycyrrhizae radix et rhizoma as examples |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6222803/ https://www.ncbi.nlm.nih.gov/pubmed/30111723 http://dx.doi.org/10.3390/molecules23082042 |
work_keys_str_mv | AT liqiao acompositivestrategytostudythepharmacokineticsoftcmstakingcoptidisrhizomaandcoptidisrhizomaglycyrrhizaeradixetrhizomaasexamples AT yangyan acompositivestrategytostudythepharmacokineticsoftcmstakingcoptidisrhizomaandcoptidisrhizomaglycyrrhizaeradixetrhizomaasexamples AT zhouting acompositivestrategytostudythepharmacokineticsoftcmstakingcoptidisrhizomaandcoptidisrhizomaglycyrrhizaeradixetrhizomaasexamples AT wangrui acompositivestrategytostudythepharmacokineticsoftcmstakingcoptidisrhizomaandcoptidisrhizomaglycyrrhizaeradixetrhizomaasexamples AT lina acompositivestrategytostudythepharmacokineticsoftcmstakingcoptidisrhizomaandcoptidisrhizomaglycyrrhizaeradixetrhizomaasexamples AT zhengmin acompositivestrategytostudythepharmacokineticsoftcmstakingcoptidisrhizomaandcoptidisrhizomaglycyrrhizaeradixetrhizomaasexamples AT liyuanyuan acompositivestrategytostudythepharmacokineticsoftcmstakingcoptidisrhizomaandcoptidisrhizomaglycyrrhizaeradixetrhizomaasexamples AT zhangjiquan acompositivestrategytostudythepharmacokineticsoftcmstakingcoptidisrhizomaandcoptidisrhizomaglycyrrhizaeradixetrhizomaasexamples AT wufei acompositivestrategytostudythepharmacokineticsoftcmstakingcoptidisrhizomaandcoptidisrhizomaglycyrrhizaeradixetrhizomaasexamples AT yangbaican acompositivestrategytostudythepharmacokineticsoftcmstakingcoptidisrhizomaandcoptidisrhizomaglycyrrhizaeradixetrhizomaasexamples AT mayueming acompositivestrategytostudythepharmacokineticsoftcmstakingcoptidisrhizomaandcoptidisrhizomaglycyrrhizaeradixetrhizomaasexamples AT mabingliang acompositivestrategytostudythepharmacokineticsoftcmstakingcoptidisrhizomaandcoptidisrhizomaglycyrrhizaeradixetrhizomaasexamples AT liqiao compositivestrategytostudythepharmacokineticsoftcmstakingcoptidisrhizomaandcoptidisrhizomaglycyrrhizaeradixetrhizomaasexamples AT yangyan compositivestrategytostudythepharmacokineticsoftcmstakingcoptidisrhizomaandcoptidisrhizomaglycyrrhizaeradixetrhizomaasexamples AT zhouting compositivestrategytostudythepharmacokineticsoftcmstakingcoptidisrhizomaandcoptidisrhizomaglycyrrhizaeradixetrhizomaasexamples AT wangrui compositivestrategytostudythepharmacokineticsoftcmstakingcoptidisrhizomaandcoptidisrhizomaglycyrrhizaeradixetrhizomaasexamples AT lina compositivestrategytostudythepharmacokineticsoftcmstakingcoptidisrhizomaandcoptidisrhizomaglycyrrhizaeradixetrhizomaasexamples AT zhengmin compositivestrategytostudythepharmacokineticsoftcmstakingcoptidisrhizomaandcoptidisrhizomaglycyrrhizaeradixetrhizomaasexamples AT liyuanyuan compositivestrategytostudythepharmacokineticsoftcmstakingcoptidisrhizomaandcoptidisrhizomaglycyrrhizaeradixetrhizomaasexamples AT zhangjiquan compositivestrategytostudythepharmacokineticsoftcmstakingcoptidisrhizomaandcoptidisrhizomaglycyrrhizaeradixetrhizomaasexamples AT wufei compositivestrategytostudythepharmacokineticsoftcmstakingcoptidisrhizomaandcoptidisrhizomaglycyrrhizaeradixetrhizomaasexamples AT yangbaican compositivestrategytostudythepharmacokineticsoftcmstakingcoptidisrhizomaandcoptidisrhizomaglycyrrhizaeradixetrhizomaasexamples AT mayueming compositivestrategytostudythepharmacokineticsoftcmstakingcoptidisrhizomaandcoptidisrhizomaglycyrrhizaeradixetrhizomaasexamples AT mabingliang compositivestrategytostudythepharmacokineticsoftcmstakingcoptidisrhizomaandcoptidisrhizomaglycyrrhizaeradixetrhizomaasexamples |